)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Agfa-Gevaert
Agfa-Gevaert (AGFB) investor relations material
Agfa-Gevaert Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary26 Aug, 2026
Executive summary
Q2 2026 delivered resilient results with stable revenue, strong Digital Printing Solutions growth, and improved Imaging and Chemicals profitability, while HealthCare IT continued its cloud transition and Green Hydrogen Solutions faced market weakness.
Transformation and restructuring programs yielded significant cost savings, with annualized savings reaching €61 million, but also led to negative free cash flow.
Net loss for Q2 was €15 million, compared to a €30 million profit in Q2 2025, mainly due to transformation costs and the absence of prior year arbitration gains.
Adjusted EBITDA improved to €14 million in Q2, supported by operational improvements and cost-saving measures.
Financial highlights
Q2 2026 group revenue was €275 million, down 0.7% year-over-year excluding currency effects; adjusted EBITDA rose to €14 million (5.0% of sales).
Gross profit margin declined to 29.0% from 30.4% year-over-year.
Free cash flow for Q2 was negative €10 million, mainly due to transformation and restructuring outflows.
Net financial debt increased to €74 million at Q2 2026, reflecting negative free cash flow.
Net result for Q2 was a loss of €15 million, compared to a profit of €30 million in Q2 2025.
Outlook and guidance
HealthCare IT expects high single-digit order intake growth for 2026, with stable profitability as cloud transition continues.
Digital Printing Solutions projected to continue double-digit growth, while Green Hydrogen Solutions is not expected to recover until 2027.
Imaging and Chemicals segment forecasts revenue and profitability to exceed 2025, driven by higher silver prices and cost savings.
Full-year 2026 free cash flow expected to be more negative than 2025 due to higher transformation costs and increased silver prices.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Agfa-Gevaert
- Adjusted EBITDA surged to €12 million as revenue grew 1.7%, despite cash flow pressures.AGFB
Q1 2026 - Q4 EBITDA and cash flow surged, but FY results were pressured by Radiology Solutions' decline.AGFBQ4 2025
- Q3 2025 revenue fell 7.1% as medical film and HealthCare IT cloud transition hit profits.AGFBQ3 2025
- HealthCare IT and legal gain offset film market decline; restructuring and cost savings underway.AGFBQ2 2025
- Digital Print & Chemicals growth and Healthcare IT cloud gains offset Radiology's film decline.AGFBQ3 2024
- Q2 2024 delivered net profit, margin gains, and record Healthcare IT orders despite negative free cash flow.AGFBH1 2024
- HealthCare IT and Digital Print & Chemicals growth offset film and radiology declines in Q1 2025.AGFBQ1 2025
- Growth engines offset film decline in 2024, but restructuring led to higher losses and debt.AGFBQ4 2024
Next Agfa-Gevaert earnings date
Q3 202610 Nov, 2026
Agfa-Gevaert
Next Agfa-Gevaert earnings date
Q3 202610 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Agfa-Gevaert NV (AGFB) is a company active in design, manufacturing, and marketing of imaging systems and products. The company operates in several key sectors, with its business activities segmented into Offset Solutions, Radiology Solutions, Digital Print & Chemicals, and HealthCare IT. In the Offset Solutions sector, Agfa-Gevaert is a primary supplier to the printing industry, offering a broad range of integrated solutions that include everything from computer-to-plate systems and digital offset plates to workflow optimization software and pressroom chemicals. The Radiology Solutions segment provides hospitals worldwide with traditional and digital radiography equipment, as well as image processing software. The Digital Print & Chemicals sector caters to sign & display printing companies with wide-format inkjet printers, inks, workflow software, cutting machines, and media, alongside classic film-based products for various industrial applications. Lastly, the HealthCare IT division delivers comprehensive solutions across Imaging IT, Hospital IT, and Integrated Care, aiming to enhance healthcare delivery by improving data management, diagnostic imaging, and patient care coordination. Agfa-Gevaert NV is headquartered in Mortsel, Belgium, and its shares are listed on the Euronext Brussels.